# Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

> **NCT02277067** · PHASE4 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 200 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT02277067
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277067, "Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02277067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*